CUSIP: 53216B104
Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,484,300
-
Share change
-
+593,113
-
Total reported value
-
$89,676,630
-
Put/Call ratio
-
207%
-
Price per share
-
$5.44
-
Number of holders
-
101
-
Value change
-
+$3,415,764
-
Number of buys
-
55
-
Number of sells
-
49
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2025
-
Previous quarter:
Q4 2024
Recent filing periods for CUSIP 53216B104:
Institutional Holders of LifeMD, Inc. - COM (LFMD) as of Q1 2025
As of 31 Mar 2025,
LifeMD, Inc. - COM (LFMD) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,484,300 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, Connor, Clark & Lunn Investment Management Ltd., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, D. E. Shaw & Co., Inc., RENAISSANCE TECHNOLOGIES LLC, and CITADEL ADVISORS LLC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.